melatonin has been researched along with Skin Diseases in 8 studies
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin was given for 2 yr (20 mg/day in the first year, 10 mg/day in the second year) to 18 CS patients." | 6.72 | Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. ( Becucci, A; Benvenuti, C; Carossino, AM; Conforti, ML; Fiori, G; Generini, S; Gramigna, L; Livi, R; Matucci-Cerinic, M; Perfetto, F; Pignone, AM; Rosso, AD; Tempestini, A, 2006) |
| "The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate." | 4.84 | Cutaneous sarcoidosis therapy updated. ( Badgwell, C; Rosen, T, 2007) |
| "Melatonin was given for 2 yr (20 mg/day in the first year, 10 mg/day in the second year) to 18 CS patients." | 2.72 | Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. ( Becucci, A; Benvenuti, C; Carossino, AM; Conforti, ML; Fiori, G; Generini, S; Gramigna, L; Livi, R; Matucci-Cerinic, M; Perfetto, F; Pignone, AM; Rosso, AD; Tempestini, A, 2006) |
| "Melatonin has been experimentally implicated in skin functions such as hair growth cycling, fur pigmentation, and melanoma control, and melatonin receptors are expressed in several skin cells including normal and malignant keratinocytes, melanocytes, and fibroblasts." | 2.43 | On the role of melatonin in skin physiology and pathology. ( Fischer, TW; Semak, I; Slominski, A; Slominski, RM; Tobin, DJ; Wortsman, J; Zbytek, B; Zmijewski, MA, 2005) |
| " Penetration through skin after topical application and oral bioavailability auxit further investigations on the pharmacokinetic and pharmacodynamic actions of melatonin." | 2.40 | [Melatonin in dermatology. Experimental and clinical aspects]. ( Elsner, P; Fischer, T; Wigger-Alberti, W, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TH | 1 |
| Jung, JA | 1 |
| Kim, GD | 1 |
| Jang, AH | 1 |
| Ahn, HJ | 1 |
| Park, YS | 1 |
| Park, CS | 1 |
| Slominski, A | 1 |
| Fischer, TW | 1 |
| Zmijewski, MA | 1 |
| Wortsman, J | 1 |
| Semak, I | 1 |
| Zbytek, B | 1 |
| Slominski, RM | 1 |
| Tobin, DJ | 1 |
| Pignone, AM | 1 |
| Rosso, AD | 1 |
| Fiori, G | 1 |
| Matucci-Cerinic, M | 1 |
| Becucci, A | 1 |
| Tempestini, A | 1 |
| Livi, R | 1 |
| Generini, S | 1 |
| Gramigna, L | 1 |
| Benvenuti, C | 1 |
| Carossino, AM | 1 |
| Conforti, ML | 1 |
| Perfetto, F | 1 |
| Badgwell, C | 1 |
| Rosen, T | 1 |
| Cagnoni, ML | 1 |
| Lombardi, A | 1 |
| Cerinic, MC | 1 |
| Dedola, GL | 1 |
| Pignone, A | 1 |
| Garde, E | 1 |
| Micic, S | 1 |
| Knudsen, K | 1 |
| Angelo, HR | 1 |
| Wulf, HC | 1 |
| Fischer, T | 1 |
| Wigger-Alberti, W | 1 |
| Elsner, P | 1 |
| Grener, AC | 1 |
3 reviews available for melatonin and Skin Diseases
| Article | Year |
|---|---|
On the role of melatonin in skin physiology and pathology.
Topics: Amino Acid Sequence; Animals; Humans; Melatonin; Molecular Sequence Data; Phenotype; Receptors, Mela | 2005 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents | 2007 |
[Melatonin in dermatology. Experimental and clinical aspects].
Topics: Animals; Humans; Melatonin; Skin; Skin Diseases | 1999 |
1 trial available for melatonin and Skin Diseases
| Article | Year |
|---|---|
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Echocardiography, Doppler; Electrocardiography; Female; Humans; Immu | 2006 |
4 other studies available for melatonin and Skin Diseases
| Article | Year |
|---|---|
Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; Antioxidants; Dermatitis, Atopic; Dinitrofluorobenzene; Male; Melatonin; Mice; Skin Disease | 2009 |
Melatonin for treatment of chronic refractory sarcoidosis.
Topics: Adult; Chronic Disease; Dyspnea; Female; Humans; Lung Diseases; Melatonin; Middle Aged; Sarcoidosis; | 1995 |
8-methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism.
Topics: Adult; Animals; Antimetabolites; Female; Humans; Male; Melatonin; Methoxsalen; Middle Aged; PUVA The | 1994 |
Schizophrenia melanosis. Iatrogenic--congenital defect?
Topics: Animals; Anura; Copper; Diet; Female; Humans; Male; Melanins; Melanosis; Melatonin; Models, Biologic | 1968 |